A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice

Aim: The aim of this study was to develop machine learning (ML) models to mitigate the inappropriate request of Procalcitonin (PCT) in clinical wards. Material and methods: We built six different ML models based on both demographical data, i.e., sex and age, and laboratory parameters, i.e., cell blo...

Full description

Bibliographic Details
Main Authors: Luisa Agnello, Matteo Vidali, Anna Maria Ciaccio, Bruna Lo Sasso, Alessandro Iacona, Giuseppe Biundo, Concetta Scazzone, Caterina Maria Gambino, Marcello Ciaccio
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024025878
_version_ 1827316520951218176
author Luisa Agnello
Matteo Vidali
Anna Maria Ciaccio
Bruna Lo Sasso
Alessandro Iacona
Giuseppe Biundo
Concetta Scazzone
Caterina Maria Gambino
Marcello Ciaccio
author_facet Luisa Agnello
Matteo Vidali
Anna Maria Ciaccio
Bruna Lo Sasso
Alessandro Iacona
Giuseppe Biundo
Concetta Scazzone
Caterina Maria Gambino
Marcello Ciaccio
author_sort Luisa Agnello
collection DOAJ
description Aim: The aim of this study was to develop machine learning (ML) models to mitigate the inappropriate request of Procalcitonin (PCT) in clinical wards. Material and methods: We built six different ML models based on both demographical data, i.e., sex and age, and laboratory parameters, i.e., cell blood count (CBC) parameters, inclusive of monocyte distribution width (MDW), and C-reactive protein (CRP). The dataset included 1667 PCT measurements of different patients. Based on a PCT cut-off of 0.50 ng/mL, we found 1090 negative (65.4%) and 577 positive (34.6%) results. We performed a 70:15:15 train:validation:test splitting based on the outcome. Results: Random Forest, Support Vector Machine and eXtreme Gradient Boosting showed optimal performances for predicting PCT positivity, with an area under the curve ranging from 0.88 to 0.89. Conclusions: The ML models developed could represent a useful tool to predict PCT positivity, avoiding unusefulness PCT requests. ML models are based on laboratory tests commonly ordered together with PCT but have the great advantage to be easy to measure and low-cost.
first_indexed 2024-03-07T19:09:09Z
format Article
id doaj.art-3deb69eaf58b4a719726cd477f705a99
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T23:15:58Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-3deb69eaf58b4a719726cd477f705a992024-03-17T07:55:44ZengElsevierHeliyon2405-84402024-03-01105e26556A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practiceLuisa Agnello0Matteo Vidali1Anna Maria Ciaccio2Bruna Lo Sasso3Alessandro Iacona4Giuseppe Biundo5Concetta Scazzone6Caterina Maria Gambino7Marcello Ciaccio8Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127, Palermo, ItalyFoundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122, Milan, ItalyInternal Medicine and Medical Specialties “G. D'Alessandro”, Department of Health Promotion, Maternal and Infant Care, University of Palermo, 90127, Palermo, ItalyInstitute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127, Palermo, Italy; Department of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, ItalyDepartment of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, ItalyDepartment of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, ItalyInstitute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127, Palermo, ItalyInstitute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127, Palermo, Italy; Department of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, ItalyInstitute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, 90127, Palermo, Italy; Department of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, Italy; Corresponding author. Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Via del Vespro, 129, CAP, 90127, Palermo, Sicily, Italy.Aim: The aim of this study was to develop machine learning (ML) models to mitigate the inappropriate request of Procalcitonin (PCT) in clinical wards. Material and methods: We built six different ML models based on both demographical data, i.e., sex and age, and laboratory parameters, i.e., cell blood count (CBC) parameters, inclusive of monocyte distribution width (MDW), and C-reactive protein (CRP). The dataset included 1667 PCT measurements of different patients. Based on a PCT cut-off of 0.50 ng/mL, we found 1090 negative (65.4%) and 577 positive (34.6%) results. We performed a 70:15:15 train:validation:test splitting based on the outcome. Results: Random Forest, Support Vector Machine and eXtreme Gradient Boosting showed optimal performances for predicting PCT positivity, with an area under the curve ranging from 0.88 to 0.89. Conclusions: The ML models developed could represent a useful tool to predict PCT positivity, avoiding unusefulness PCT requests. ML models are based on laboratory tests commonly ordered together with PCT but have the great advantage to be easy to measure and low-cost.http://www.sciencedirect.com/science/article/pii/S2405844024025878Laboratory medicineSepsisProcalcitoninMDWCRPArtificial intelligence
spellingShingle Luisa Agnello
Matteo Vidali
Anna Maria Ciaccio
Bruna Lo Sasso
Alessandro Iacona
Giuseppe Biundo
Concetta Scazzone
Caterina Maria Gambino
Marcello Ciaccio
A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
Heliyon
Laboratory medicine
Sepsis
Procalcitonin
MDW
CRP
Artificial intelligence
title A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
title_full A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
title_fullStr A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
title_full_unstemmed A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
title_short A machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
title_sort machine learning strategy to mitigate the inappropriateness of procalcitonin request in clinical practice
topic Laboratory medicine
Sepsis
Procalcitonin
MDW
CRP
Artificial intelligence
url http://www.sciencedirect.com/science/article/pii/S2405844024025878
work_keys_str_mv AT luisaagnello amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT matteovidali amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT annamariaciaccio amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT brunalosasso amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT alessandroiacona amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT giuseppebiundo amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT concettascazzone amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT caterinamariagambino amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT marcellociaccio amachinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT luisaagnello machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT matteovidali machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT annamariaciaccio machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT brunalosasso machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT alessandroiacona machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT giuseppebiundo machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT concettascazzone machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT caterinamariagambino machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice
AT marcellociaccio machinelearningstrategytomitigatetheinappropriatenessofprocalcitoninrequestinclinicalpractice